Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Pebody, R.G
Gay, N.J
Hesketh, L.M
Vyse, A
Morgan-Capner, P
Brown, D.W
Litton, P
and
Miller, E
2002.
Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillance.
Vaccine,
Vol. 20,
Issue. 7-8,
p.
1134.
MacIntyre, C.R.
Gay, N.J.
Gidding, H.F.
Hull, B.P.
Gilbert, G.L.
and
McIntyre, P.B.
2002.
A mathematical model to measure the impact of the measles control campaign on the potential for measles transmission in Australia.
International Journal of Infectious Diseases,
Vol. 6,
Issue. 4,
p.
277.
Giammanco, A
Chiarini, A
Maple, P.A.C
Andrews, N
Pebody, R
Gay, N
Ölander, R.M
Fivet-Groyne, F
Baron, S
Tischer, A
Swidsinski, S
Schellekens, J
and
Reizenstein, E
2003.
European Sero-Epidemiology Network: standardisation of the assay results for pertussis.
Vaccine,
Vol. 22,
Issue. 1,
p.
112.
Orenstein, Walter A.
and
Gay, Nigel J.
2004.
The Theory of Measles Elimination: Implications for the Design of Elimination Strategies.
The Journal of Infectious Diseases,
Vol. 189,
Issue. Supplement_1,
p.
S27.
Kim, Sung-Soo
Han, Hyun Woo
Go, Unyeong
and
Chung, Hai Won
2004.
Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
Vaccine,
Vol. 23,
Issue. 3,
p.
290.
Kafatos, George
Andrews, Nick
and
Nardone, Anthony
2005.
Model selection methodology for inter-laboratory standardisation of antibody titres.
Vaccine,
Vol. 23,
Issue. 42,
p.
5022.
Feiterna-Sperling, Cornelia
Br??nnimann, Rainer
Tischer, Annedore
Stettler, Peter
Durrer, Peter
and
Gaedicke, Gerhard
2005.
Open Randomized Trial Comparing the Immunogenicity and Safety of a New Measles-Mumps-Rubella Vaccine and a Licensed Vaccine in 12- to 24-Month-Old Children.
The Pediatric Infectious Disease Journal,
Vol. 24,
Issue. 12,
p.
1083.
Domínguez, A.
Plans, P.
Costa, J.
Torner, N.
Cardenosa, N.
Batalla, J.
Plasencia, A.
and
Salleras, L.
2006.
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 25,
Issue. 5,
p.
310.
Jonsson, Maria K.
Levi, Michael
Rudén, Ulla
and
Wahren, Britta
2006.
Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study.
Scandinavian Journal of Infectious Diseases,
Vol. 38,
Issue. 5,
p.
357.
Best, Jennifer M
and
Enders, Gisela
2006.
Rubella Viruses.
Vol. 15,
Issue. ,
p.
39.
Vidor, Emmanuel
and
Crevat, Denis
2006.
L'apport du laboratoire dans les essais cliniques vaccinaux.
Revue Francophone des Laboratoires,
Vol. 2006,
Issue. 381,
p.
47.
de Ory, Fernando
Echevarría, José Manuel
Kafatos, George
Anastassopoulou, Cleo
Andrews, Nick
Backhouse, Josephine
Berbers, Guy
Bruckova, Blazena
Cohen, Daniel I.
de Melker, Hester
Davidkin, Irja
Gabutti, Giovanni
Hesketh, Louise M.
Johansen, Kari
Jokinen, Sari
Jones, Lindsay
Linde, Anika
Miller, Elisabeth
Mossong, Joël
Nardone, Anthony
Rota, Maria Cristina
Sauerbrei, Andreas
Schneider, François
Smetana, Zahava
Tischer, Annedore
Tsakris, Athanassios
and
Vranckx, Robert
2006.
European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus.
Journal of Clinical Virology,
Vol. 36,
Issue. 2,
p.
111.
Cohen, D.
Muhsen, Kh.
Aboudy, Y.
Harari, H.
Mendelson, E.
and
Green, M.S.
2006.
Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
Vaccine,
Vol. 24,
Issue. 27-28,
p.
5604.
Ovsyannikova, Inna G.
Jacobson, Robert M.
Ryan, Jenna E.
Dhiman, Neelam
Vierkant, Robert A.
and
Poland, Gregory A.
2007.
Relationship between HLA Polymorphisms and Gamma Interferon and Interleukin-10 Cytokine Production in Healthy Individuals after Rubella Vaccination.
Clinical and Vaccine Immunology,
Vol. 14,
Issue. 2,
p.
115.
Tischer, Annedore
Gassner, Markus
Richard, Jean-Luc
Suter-Riniker, Franziska
Mankertz, Annette
and
Heininger, Ulrich
2007.
Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests.
Journal of Clinical Virology,
Vol. 38,
Issue. 3,
p.
204.
Vainio, K.
Samdal, H. H.
Ånestad, G.
Skutlaberg, D. H.
Bransdal, K. T.
Mundal, R.
and
Aaberge, I.
2007.
Seroprevalence of measles among Norwegian military conscripts in 2004.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 26,
Issue. 3,
p.
217.
TISCHER, A.
ANDREWS, N.
KAFATOS, G.
NARDONE, A.
BERBERS, G.
DAVIDKIN, I.
ABOUDY, Y.
BACKHOUSE, J.
BARBARA, C.
BARTHA, K.
BRUCKOVA, B.
DUKS, A.
GRISKEVICIUS, A.
HESKETH, L.
JOHANSEN, K.
JONES, L.
KUERSTEINER, O.
LUPULESCU, E.
MIHNEVA, Z.
MRAZOVA, M.
DE ORY, F.
PROSENC, K.
SCHNEIDER, F.
TSAKRIS, A.
SMELHAUSOVA, M.
VRANCKX, R.
ZARVOU, M.
and
MILLER, E.
2007.
Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.
Epidemiology and Infection,
Vol. 135,
Issue. 5,
p.
787.
Kafatos, G.
Anastassopoulou, C.
Nardone, A.
Andrews, N.
Barbara, C.
Boot, H. J.
Butur, D.
Davidkin, I.
Gelb, D.
Griskevicius, A.
Hesketh, L.
Icardi, G.
Jones, L.
Kra‐Oz, Z.
Miller, E.
Mossong, J.
Nemecek, V.
De Ory, F.
Sobotová, Z.
Thierfelder, W.
Van Damme, P.
and
Hatzakis, A.
2007.
The European Sero‐Epidemiology Network 2: standardization of assay results for hepatitis B virus.
Journal of Viral Hepatitis,
Vol. 14,
Issue. 4,
p.
260.
Giammanco, Anna
Nardone, Antony
Pebody, Richard
Kafatos, George
Andrews, Nick
Chiarini, Alfredo
Taormina, Susanna
de Ory, Fernando
Prosenc, Katarina
Krize, Bohumir
Hallander, Hans
Ljungman, Margaretha
Marva, Esther
Tsakris, Athanassios
O’Flanagan, Darina
Schneider, François
Griskevicius, Algirdas
Vranckx, Robert
and
Karacs, Ildiko
2008.
European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
Vaccine,
Vol. 26,
Issue. 35,
p.
4486.
ANASTASSOPOULOU, C. G.
KAFATOS, G.
NARDONE, A.
ANDREWS, N.
PEBODY, R. G.
MOSSONG, J.
DAVIDKIN, I.
GELB, D.
DE ORY, F.
THIERFELDER, W.
NEMECEK, V.
BRUZZONE, B.
BUTUR, D.
BARBARA, C.
SOBOTOVÁ, Z.
JONES, L.
GRISKEVICIUS, A.
HESKETH, L. M.
COHEN, D.
VRANCKX, R.
TSAKRIS, A.
MILLER, E.
and
HATZAKIS, A.
2009.
The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries.
Epidemiology and Infection,
Vol. 137,
Issue. 4,
p.
485.